Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Sees Stock Upgraded to the Toronto Stock Exchange Main Board
March 15, 2023
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently revealed that the company had seen its corporate listing upgraded to trade on the TSX exchange from the TSX-V market as of Monday, March 6th, 2023. The […]
Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Is ‘One to Watch’
March 15, 2023
Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) is a battery minerals company providing shareholders exposure to the global mega-trend of electrification while being focused on growth through cash-flow, exploration and acquisitions in favorable mining jurisdictions. The company’s mission is the discovery, acquisition and development of battery metals (namely copper, cobalt, lithium, and graphite) in North […]
InvestorNewsBreaks – CubCrafters Aircraft Achieves ‘Milestone’ with Bulls Eye Landing on Dubai Hotel
March 14, 2023
CubCrafters, a light-sport, experimental, and backcountry aircraft company, has achieved a milestone: the successful landing of a fixed wing Carbon Cub aircraft on one of the world’s most iconic building, the Burj Al Arab hotel, in Dubai, UAE. CubCrafters collaborated with Red Bull and extreme sports promotor XDubai to accomplish what it called the Bulls […]
InvestorNewsBreaks — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Fourth-Quarter, Year-End 2022 Report
March 14, 2023
McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, has released numbers for Q4 and year-end 2022, both for the period ending Dec. 31, 2022. Highlights of the report included MUX subsidiary McEwen Copper completing three tranches of financing, raising $81.9 million in total; production […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive Findings from its DIAB-A22-1 Animal Model Study on Potential DehydraTECH-CBD(TM) Treatment for Diabetes
March 14, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the completion of its DIAB-A22-1 animal model study, which explored the potential of the patented DehydraTECH(TM)-processed CBD to treat diabetes. Of note were three positive outcomes, including an improvement in general activity, reductions in body weight, and better triglyceride and cholesterol levels. […]
InvestorNewsBreaks – Upstream Hits 5K Milestone, Continues Welcoming the Future of Trading
March 10, 2023
Upstream, a MERJ Exchange market, announced that it has recently reached a significant milestone of 5,000 users and counting that have joined its trading community. The achievement comes on the heels of Upstream’s welcoming of multiple dual-listing issuers since the beginning of the year, as well as success with its digital coupon NFT strategy and […]
IBN Announces CryptoCurrencyWire Audio Production Featuring Michael Amar, Chairman of Paris Blockchain Week
March 10, 2023
LOS ANGELES, March 10, 2023 (GLOBE NEWSWIRE) — via InvestorWire — IBN, a multifaceted communications organization, is pleased to announce the release of the latest CryptoCurrencyWire Audio Production as part of its sustained effort to provide specialized content distribution via widespread syndication channels. CryptoCurrencyWire’s latest audio production features Michael Amar, Chairman of Paris Blockchain Week, one of the most influential global […]
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Updates Shareholders, Provides Company Overview and Plans for Future
March 9, 2023
Predictive Oncology (NASDAQ: POAI) CEO Raymond Vennare has issued a letter to shareholders, providing an overview of the company and a look at the significant progress the company has made in respect to validating its commercial platform and publishing its proof of concept. In the letter, Vennare noted that Predictive Oncology is now in a […]
InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Makes Changes in Senior Leadership Roles
March 8, 2023
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, has made key leadership changes. The company announced that HeartBeam president Robert Eno has been appointed executive vice president while current chief business officer Jon Hunt, PhD, will transition into the […]
D-Wave Quantum Inc. (NYSE: QBTS) Ushers in Commercial Quantum Computing, Helping Business Leaders Drive Operational Efficiencies Amid Complex Market Environment
March 8, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering customer value via practical quantum applications, was recently featured in an article by TBD Media on the Reuters website titled Quantum Computing Emerges as Key to Solving Complex Business Problems (https://ibn.fm/EFJ6j). The company was profiled as one of “50 […]
BlockQuarry Announces Q2 Operational and Growth Strategy Forecast
March 8, 2023
HOUSTON, March 08, 2023 (GLOBE NEWSWIRE) — via InvestorWire — BlockQuarry Corp. (OTC: BLQC) (“BlockQuarry” or the “Company”), a Texas-based company with commercial-stage operations in the energy and infrastructure industry focusing on cryptocurrency hosting and self-mining with a focus on Bitcoin, is pleased to announce the following to its shareholders. The Company has announced its […]
InvestorNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Clinical Trial of Jellyfish Sting Prevention Sunscreen on Man-O-War
March 7, 2023
Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair, skin, and sexual wellness, has launched a clinical trial designed to explore the effectiveness of an improved formulation of NoStingz jellyfish sting prevention sunscreen against man-o-war jellyfish. The trial, which will be led by Dr. Patric Rice and Dr. Eric Stroud, will be conducted by […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in Upcoming Oppenheimer Healthcare Conference
March 7, 2023
Processa Pharmaceuticals (NASDAQ: PCSA), the developer of the next-generation chemotherapy drugs that will provide a better safety-efficacy profile than widely used FDA-approved counterparts, will be presenting at the 33rd annual Oppenheimer Healthcare Conference, held on March 14, 2023. According to the announcement, Processa Pharmaceuticals CEO and president Dr. David Young is scheduled for a virtual […]
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receive First Payment on ‘Milestone’ Purchase of Cancer Detection Equipment
March 7, 2023
AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection, received the first payment in late February 2023 from a Malaysian customer that had purchased AnPac Bio’s Model AP9080 cancer detection devices. The contract for these devices totaled $1.5 million. According to the announcement, the proprietary Model AP9080 features […]
Lexaria Bioscience Corp. (NASDAQ: LEXX), a Global Innovator in Drug Delivery Platforms, Holds Discussions With Several Larger Companies on Path to Commercialization of DehydraTECH(TM) Technology
March 7, 2023
In 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology, achieved several important goals for the year, according to CEO Chris Bunka. “One of our biggest achievements of 2022 was our greater emphasis on commercial pursuits,” Bunka wrote in his January 2023 letter to shareholders (https://ibn.fm/SPqK7). This […]
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Retains Top Banking Firm to Support Growth, Revenue-Generating Strategy
March 3, 2023
Aditxt Inc. (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, announced that it is working with Riverside Management Group LLC, a merchant banking firm providing investment banking advisory services; RMG will be supporting Aditxt’s strategic growth and revenue generating plans for its subsidiary Pearsanta Inc., […]
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call
March 2, 2023
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, today announced its plans to host a conference call to discuss its results for the fourth quarter and full fiscal year ended Dec. 31, 2022. The call is scheduled to start […]
InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Featured in New Goldman Small Cap Research Report
March 1, 2023
QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases and conditions, is spotlighted in a new opportunity research report released by Goldman Small Cap Research. A stock market research company specializing in the small cap and microcap sectors, Goldman reviewed QSAM’s […]
D-Wave Quantum Inc. (NYSE: QBTS) Announces Product and Business Updates, Including AI/Machine Learning Offering and Expansion of Quantum Cloud Service to Israel
March 1, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services is transforming multiple industries as the world’s first commercial supplier of quantum computing solutions. D-Wave recently announced a series of product and business updates demonstrating the company’s continued progress and the momentum of its leadership in driving quantum commercialization, including a broad […]
Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Kicks Off New Year with New Look
March 1, 2023
Cerberus Cyber Sentinel (NASDAQ: CISO) is starting off the new year with a new name, brand and logo (https://ibn.fm/Mxai7). The company, which has established itself as a leading cybersecurity and compliance provider, has announced plans for a corporate rebrand and launch designed to reflect the company’s global mission. “At the heart of the rebranding is […]
InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Completion of Enrollment for Phase 1 CycloSam Study
February 28, 2023
QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases and conditions, has completed enrollment in its first participant grouping, or cohort, for its upcoming phase 1 study. The study is designed to evaluate CycloSam in the treatment of bone cancer. The […]
D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Customer Engagements and Cross-Platform Product Enhancements During Qubits 2023 Convention
February 24, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing and gate-model quantum computing solutions during the company’s annual Qubits 2023 user conference. The company’s continued commercial customer momentum and […]
InvestorNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Begins Trading on Toronto Stock Exchange
February 23, 2023
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) has obtained conditional approval to list its common shares on the Toronto Stock Exchange (“TSX”). According to the announcement, Eloro shares will trade under the trading symbol: ELO. The announcement also noted that the listing is subject to Eloro Resources fulfilling certain requirements of the TSX; those […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plan to Streamline Efforts, Maximize Efficiency, Focus on Clinical Trials
February 23, 2023
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced a strategic plan designed to streamline efforts, maximize operating efficiency and focus on critical clinical trials, including near-term, mid-term and long-term milestones. A part of that plan was the release of an estimated 15% of Cybin’s workforce, including those […]
IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Return of Dr. Alan Baratz, CEO of D-Wave Quantum Inc.
February 22, 2023
LOS ANGELES, Feb. 22, 2023 (GLOBE NEWSWIRE) — via InvestorWire — IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
InvestorNewsBreaks – Infinity Stone Ventures Corp. (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) Eyes Dual Listing to Reach Untapped International Market
February 21, 2023
Infinity Stone (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) today announce that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited. The planned dual listing is designed to provide the company with the opportunity to […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Prioritizes Development of Next Generation Chemotherapies
February 21, 2023
Processa Pharmaceuticals (NASDAQ: PCSA) today reiterates the strategic prioritization of its pipeline of proprietary oncology drugs, defined as Next Generation Chemotherapies (“NGCs”). According to the update, previous studies with these NGCs suggest potential improvement in the safety-efficacy profile, significantly differentiating these NGCs from their three presently widely used counterparts – capecitabine, gemcitabine and irinotecan. “The […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Foster New Partnerships with its Expanding DehydraTECH(TM) Licensing Opportunities
February 21, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since 2016, repeatedly demonstrated the potential of its patented technology, DehydraTECH(TM). The technology improves how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods while increasing the effectiveness of fat-soluble active molecules. With the help of this technology, Lexaria […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report
February 21, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the […]
InvestorNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Targeting Ambitious Development Milestones in 2023
February 17, 2023
Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a developer of next-gen technologies for EV powertrains and grid-connected renewable energy systems, remains committed to building momentum gained in 2022. “As the previous year drew to a close, this developer of transformative power conversion technologies and control system solutions for modern electrical systems validated its zero-voltage switching (‘ZVS’) inverter […]
Commercial Quantum Computing Center Stage at D-Wave Quantum Inc. (NYSE: QBTS) Qubits23 Conference
February 16, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering practical quantum applications, and the only provider building both annealing and gate-model quantum computers, recently held its Qubits23 user conference in Miami, Florida. Providing valuable information, demos, and scientific talks, the conference served as an important opportunity for attendees […]
AmeriCann Reports Four Consecutive Quarters of Positive Net Income
February 16, 2023
DENVER, Feb. 16, 2023 (GLOBE NEWSWIRE) — via InvestorWire — AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, has released financial and operational results for its quarter ending December 2022. “AmeriCann’s focus on financial performance has produced excellent results, with four consecutive quarters of positive […]
InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Lead NanoAb Candidate Demonstrates Significant Advantages
February 15, 2023
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently achieved key milestones. These include the demonstration of statistically significant positive results from a preclinical in-vivo proof-of-concept study of its inhaled anti-COVID-19 nanosized antibodies (“NanoAbs”). “Its lead NanoAb candidate, designed […]
InvestorNewsBreaks – Sugarmade Inc. (SGMD) Releases Letter to Shareholders, Corporate Update
February 15, 2023
Sugarmade (OTC: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, today issued a letter to shareholders from its Chief Executive Officer Jimmy Chan. “Pivoting toward new opportunities is an essential element of good stewardship, and Sugarmade continues to welcome favorable developments in its corporate structure. While the optics […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $6.25M Registered Direct Offering
February 15, 2023
Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing next-generation chemotherapy drugs for patients who have unmet medical conditions and/or require better treatment options to improve a patient’s survival and/or quality of life, announced that it has closed on its registered direct offering. The company noted that the $6.25 million offering included definitive agreements with […]
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Mat Sorensen, Author of The Self Directed IRA Handbook
February 15, 2023
LOS ANGELES, Feb. 15, 2023 (GLOBE NEWSWIRE) — via InvestorWire — IBN, a multifaceted communications organization engaged in connecting companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and […]
InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Q1 2023 Fiscal, Business Report
February 15, 2023
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its fiscal first quarter for the period ending Dec. 31, 2022. Highlights of the report include the following: acquiring the assets of Electric Last Mile Solutions (“ELMS”) in a $105 million acquisition move; $100 million in cash being available for operations and […]
InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Report, Corporate Update for Q3
February 15, 2023
India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) is reporting on its financial and corporate performance for the third fiscal quarter 2023. Highlights of the report include a focus on the company’s phase 2 clinical trial on IGC-AD1 for agitation in dementia from Alzheimer’s disease. The company reports that the number of sites participating […]
Sugarmade (SGMD) Issues Shareholder Letter and 2023 Corporate Update
February 15, 2023
NEW YORK, Feb. 15, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Sugarmade, Inc. (OTC Pink: SGMD) (“Sugarmade,” “SGMD” or the “Company”), a product and branding marketing company investing in operations and technologies with disruptive potential, is pleased to issue the following letter to shareholders from Chief Executive Officer Jimmy Chan. Dear Valued Shareholder, Pivoting toward […]
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
February 15, 2023
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022 POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc. (dba IGC, Inc.) (NYSE American: IGC) (“IGC” or the “Company”) today reported its third fiscal quarter 2023 financial results. Third Fiscal Quarter 2023 Highlights: Ram Mukunda, CEO of […]